Regulation of antinucleoprotein IgG by systemic vaccination and its effect on influenza virus clearance. - Wikidata - thesis-toulmin - TriplyDB

Regulation of antinucleoprotein IgG by systemic vaccination and its effect on influenza virus clearance.

Regulation of antinucleoprotein IgG by systemic vaccination and its effect on influenza virus clearance.

http://www.wikidata.org/entity/Q30400347

about

Developing Universal Influenza Vaccines: Hitting the Nail, Not Just on the Head Intranasal Immunization with Pressure Inactivated Avian Influenza Elicits Cellular and Humoral Responses in Mice Immune Responses to Influenza Virus and Its Correlation to Age and Inherited Factors Simulated Respiratory Secretion for Use in the Development of Influenza Diagnostic Assays.Diet-induced obese mice exhibit altered heterologous immunity during a secondary 2009 pandemic H1N1 infection A GFP-tagged nucleoprotein-based aggregation assay for anti-influenza drug discovery and antibody development.Immunologic characterization of a rhesus macaque H1N1 challenge model for candidate influenza virus vaccine assessment.Influenza vaccines: a moving interdisciplinary field.Distinct patterns of B-cell activation and priming by natural influenza virus infection versus inactivated influenza vaccination.H1N1 viral proteome peptide microarray predicts individuals at risk for H1N1 infection and segregates infection versus Pandemrix(®) vaccination.A polyvalent influenza DNA vaccine applied by needle-free intradermal delivery induces cross-reactive humoral and cellular immune responses in pigs.Generation and Protective Ability of Influenza Virus-Specific Antibody-Dependent Cellular Cytotoxicity in Humans Elicited by Vaccination, Natural Infection, and Experimental Challenge.Non-neutralizing antibodies induced by seasonal influenza vaccine prevent, not exacerbate A(H1N1)pdm09 disease.Immunogenicity and Cross Protection in Mice Afforded by Pandemic H1N1 Live Attenuated Influenza Vaccine Containing Wild-Type Nucleoprotein.Seasoned adaptive antibody immunity for highly pathogenic pandemic influenza in humans.Cold-adapted influenza and recombinant adenovirus vaccines induce cross-protective immunity against pH1N1 challenge in mice.Seasonal H1N1 influenza virus infection induces cross-protective pandemic H1N1 virus immunity through a CD8-independent, B cell-dependent mechanism.Antibodies against conserved antigens provide opportunities for reform in influenza vaccine design Influenza A virus nucleoprotein derived from Escherichia coli or recombinant vaccinia (Tiantan) virus elicits robust cross-protection in mice Influenza nucleoprotein delivered with aluminium salts protects mice from an influenza A virus that expresses an altered nucleoprotein sequence.The prospects and challenges of universal vaccines for influenza Prolonged antigen presentation by immune complex-binding dendritic cells programs the proliferative capacity of memory CD8 T cells.Intranasal delivery of influenza rNP adjuvanted with c-di-AMP induces strong humoral and cellular immune responses and provides protection against virus challenge.Distinct cross-reactive B-cell responses to live attenuated and inactivated influenza vaccines Robust immunity and heterologous protection against influenza in mice elicited by a novel recombinant NP-M2e fusion protein expressed in E. coli Cooperativity between CD8+ T cells, non-neutralizing antibodies, and alveolar macrophages is important for heterosubtypic influenza virus immunity.The nucleocapsid protein of Rift Valley fever virus is a potent human CD8+ T cell antigen and elicits memory responses Vaccination to conserved influenza antigens in mice using a novel Simian adenovirus vector, PanAd3, derived from the bonobo Pan paniscus.Viremic HIV Controllers Exhibit High Plasmacytoid Dendritic Cell-Reactive Opsonophagocytic IgG Antibody Responses against HIV-1 p24 Associated with Greater Antibody Isotype Diversification.Broadly protective immunity against divergent influenza viruses by oral co-administration of Lactococcus lactis expressing nucleoprotein adjuvanted with cholera toxin B subunit in mice.Immunity to the conserved influenza nucleoprotein reduces susceptibility to secondary bacterial infections Induction of cross-protection against influenza A virus by DNA prime-intranasal protein boost strategy based on nucleoprotein.What Lies Beneath: Antibody Dependent Natural Killer Cell Activation by Antibodies to Internal Influenza Virus Proteins.Standard trivalent influenza virus protein vaccination does not prime antibody-dependent cellular cytotoxicity in macaques.Vaccine efficacy and T helper cell differentiation change with aging.Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model.Inter-Clade Protection Offered by Mw-Adjuvanted Recombinant HA, NP Proteins, and M2e Peptide Combination Vaccine in Mice Correlates with Cellular Immune Response.Viva la revolución: rethinking influenza a virus antigenic drift.Evasion of influenza A viruses from innate and adaptive immune responses.Development of a universal CTL-based vaccine for influenza.

P2860

Q26783897-6DEC9541-3205-4B13-A50A-E85239750109 Q27305076-F43E0E3F-C154-485F-B7A7-60B37EB7C69E Q28075495-0BA99BD0-F0B2-4389-8DBC-9FDECF873E10 Q30151592-2B8E0DDB-1AE3-43A2-ACF0-4FDE9543FCEE Q30352501-3493EC69-71EC-474D-98EB-CC74DA56069D Q30352981-8E469A70-8EA1-4C4D-8EF2-DC6841575B07 Q30367637-6F1FC719-8089-4354-B8A9-EB08EC3B65F0 Q30367695-8F16EB7E-0529-415B-95CD-C82D84CE1C31 Q30368005-DF2E4C04-3D63-4401-9CEC-ACE7247B7039 Q30371297-A358E615-C80A-4878-898E-8DF67432F897 Q30388390-CE609ADF-B980-49AB-A5C5-56A48292B7DD Q30389916-A5057641-04D6-472C-8D7D-673E78D5E086 Q30395259-6A888564-660E-44D4-9040-07BCE55A93FF Q30398731-A631EAA2-488A-4561-A848-3B0B4DA98185 Q30403507-84731C85-BD7B-48F2-A111-5AB8EF7129A6 Q30405211-93172C10-F085-4976-9C5B-94A93209460D Q30410126-B6825775-5A36-4F3D-9F0C-BCE3B23F4F72 Q30416502-09E25391-288B-4B6A-894F-A4CE49A3C4D9 Q30425194-C39A66D1-6E23-4192-A6BE-AA8ABF52AC79 Q30429719-7F2728C4-90BE-491D-81A7-C8E4571D6E7C Q30430703-09212F8E-8F4E-4EED-B28C-43DE27E53F9F Q33964275-63F4C84C-8598-449C-8CC9-D33E23EE3D23 Q34070683-3171233B-9283-4001-AA07-569804E74259 Q34354440-C10D7FF2-CACA-4B14-B4CC-8A3EC9574FFE Q34533990-177CD1BD-ADEE-486D-B03D-A3EEC9177BE4 Q34629133-2F110A70-1C7C-44B8-9E9E-0F47F8082F63 Q34634852-48737167-0AA2-4B4A-A266-A4AC131911D0 Q34638916-95F561A2-72A3-4A2B-8C1C-43FAAC9F9DE7 Q35823060-D1025821-F7CB-464C-B0FF-5E4D750D952B Q35913758-08B7CE5E-26F4-431B-9FBE-E90AACDA8FA8 Q36374228-B1598257-FCF1-4ACB-ADFC-590D832C3FB4 Q36437406-17098EBD-5DFC-4C02-830A-D52CB1EA79F4 Q37034475-B84E7D82-E01F-4781-929A-30E6491D5E9A Q37336804-90702E01-D3FE-4980-A2BF-FC31807B97A3 Q37376099-CB77EE9F-5D67-4D11-8225-F5A3ECB2FFCC Q37452408-9A169721-1EAE-4098-BEBA-5FAD318FD264 Q37570525-3815A557-D37D-418D-A92B-68470125CFED Q37950365-E46FC302-1329-4B09-B000-0FDE301D690C Q38061423-9A486C07-EC4C-4DFF-AB53-7123E28E583A Q38075677-FF937350-F9D9-49AE-95F4-FD8C667DEEBE

P2860

Regulation of antinucleoprotein IgG by systemic vaccination and its effect on influenza virus clearance.

http://www.wikidata.org/entity/Q30400347

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Regulation of antinucleoprotei ...... on influenza virus clearance.

@ast

Regulation of antinucleoprotei ...... on influenza virus clearance.

@en

type

label

Regulation of antinucleoprotei ...... on influenza virus clearance.

@ast

Regulation of antinucleoprotei ...... on influenza virus clearance.

@en

prefLabel

Regulation of antinucleoprotei ...... on influenza virus clearance.

@ast

Regulation of antinucleoprotei ...... on influenza virus clearance.

@en

P1433

Q30400347-83359638-93FF-4461-A2ED-901B1573D850

P1476

Q30400347-D819FFC9-7448-47AE-8BE9-E934E69EB076

P2093

Q30400347-28BB49FB-9AE0-4BEA-A757-741AD3930D5B

Q30400347-51C6EE51-4FFA-47F5-8D5E-69FFB0D45AC2

Q30400347-52BCFB54-7FB4-4198-ABF9-8B756D2D3A3F

Q30400347-57A0A5C3-CBBC-405E-A359-8A744C3458BE

Q30400347-5C38B3F2-BD7B-459E-A3EE-AB022F3C348D

Q30400347-E0DB5326-3FA7-4AA6-8224-FBB316F4A811

Q30400347-E69CFAEF-2888-44E9-967A-1A8EB8F157DB

Q30400347-F17130AD-4DD5-4747-BFD2-288E9602C5D8

Q30400347-F458A3B5-604B-4D88-9178-BA2CCAFEB942

P2860

Q30400347-03D311AA-18BA-49F7-ADB3-E1B60602E0C6

Q30400347-049745C6-87E1-40F3-BA4B-263C779C1A16

Q30400347-07ECD86F-651E-4816-AEFD-34B4512B639A

Q30400347-08536E7C-4CDD-4012-BFFF-39A77C5BF664

Q30400347-085D79E4-7C21-42E5-B7EF-649354F1B147

Q30400347-0BB1E602-92B6-4537-897D-660F71175757

Q30400347-0F4EDB27-2988-467D-A34D-18F7CDC0FBE6

Q30400347-10071A1E-0AA0-4DB3-8544-972A4B45B037

Q30400347-10AF93F7-AD49-4114-8900-3E0738793323

Q30400347-2AC2111F-73E2-459E-AB2D-49F84DDB7F40

P304

Q30400347-940CA890-1F7D-474A-9CE1-5E8346586D0A

P31

Q30400347-5F39DEDB-94DC-4BF2-BB46-8651C40174E7

P356

Q30400347-057DF3CC-FEB9-4828-B8E8-06295A19173D

P433

Q30400347-5C7ABC90-C8A7-47AC-90A3-108ADA949768

P478

Q30400347-3E9D7DB6-063C-4F83-97D9-47CE311D8A7E

P577

Q30400347-C89D937E-C90F-4DCB-9E85-0FD2C40ECEF2

P5875

Q30400347-FA455F9D-9D7C-4809-B622-C266DE557A58

P698

Q30400347-83BEA561-818E-4458-B603-1A3A85A87B31

P932

Q30400347-E699B8F3-6F7F-4CF4-A598-D28049298AF7

P356

P1433

Journal of Virology

P1476

Regulation of antinucleoprotei ...... on influenza virus clearance.

@en

P2093

Amy Moquin

http://www.w3.org/2001/XMLSchema#string

Denise A Kaminski

http://www.w3.org/2001/XMLSchema#string

F Eun-Hyung Lee

http://www.w3.org/2001/XMLSchema#string

Frances E Lund

http://www.w3.org/2001/XMLSchema#string

Laura Haynes

http://www.w3.org/2001/XMLSchema#string

Mark W Lamere

http://www.w3.org/2001/XMLSchema#string

Patrick J Blair

http://www.w3.org/2001/XMLSchema#string

Ravi S Misra

http://www.w3.org/2001/XMLSchema#string

Troy D Randall

http://www.w3.org/2001/XMLSchema#string

P2860

Pandemic potential of a strain of influenza A (H1N1): early findings

Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

Influenza update 2007-2008: vaccine advances, pandemic preparation

2008-2009 Influenza update: a better vaccine match

Emergence and pandemic potential of swine-origin H1N1 influenza virus

Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic

In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses

Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands.

Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function.

P304

5027-5035

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.00150-11

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50266889

http://www.w3.org/2001/XMLSchema#string

P698

21367900

http://www.w3.org/2001/XMLSchema#string

P932

3126167

http://www.w3.org/2001/XMLSchema#string